111 related articles for article (PubMed ID: 14726694)
21. [Early diagnosis of cutaneous melanoma and its precursors. Importance of the clinical characteristics of thin melanoma].
Cristofolini M; Zumiani G; Boi S; Piscioli F; Qiqi C
Minerva Med; 1986 Sep; 77(37):1673-8. PubMed ID: 3763038
[TBL] [Abstract][Full Text] [Related]
22. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma.
Clark WH; Elder DE; Guerry D; Epstein MN; Greene MH; Van Horn M
Hum Pathol; 1984 Dec; 15(12):1147-65. PubMed ID: 6500548
[TBL] [Abstract][Full Text] [Related]
23. Regulation of melanotransferrin gene in melanoma cells. Analysis of the enhancer region.
Rozé A; Zakin MM; Duchange N
Biochim Biophys Acta; 1995 Feb; 1260(3):301-7. PubMed ID: 7873604
[TBL] [Abstract][Full Text] [Related]
24. Expression of MAGE genes in ocular melanoma during progression from primary to metastatic disease.
Chen PW; Murray TG; Uno T; Salgaller ML; Reddy R; Ksander BR
Clin Exp Metastasis; 1997 Sep; 15(5):509-18. PubMed ID: 9247253
[TBL] [Abstract][Full Text] [Related]
25. The melanoma progression-associated antigen P3.58 is identical to the intercellular adhesion molecule, ICAM-1.
Johnson JP; Stade BG; Hupke U; Holzmann B; Riethmüller G
Immunobiology; 1988 Dec; 178(3):275-84. PubMed ID: 3229781
[TBL] [Abstract][Full Text] [Related]
26. CTp11, a novel member of the family of human cancer/testis antigens.
Zendman AJ; Cornelissen IM; Weidle UH; Ruiter DJ; van Muijen GN
Cancer Res; 1999 Dec; 59(24):6223-9. PubMed ID: 10626816
[TBL] [Abstract][Full Text] [Related]
27. Antigenic phenotype of pigment cell lesions: a study of melanoma, its precursor lesions and heterogeneity in metastatic melanoma.
Ernstoff MS; Duray P; Stenn K; Kirkwood JM
J Invest Dermatol; 1985 May; 84(5):430-2. PubMed ID: 3889169
[TBL] [Abstract][Full Text] [Related]
28. Heterogeneous expression of the SSX cancer/testis antigens in human melanoma lesions and cell lines.
dos Santos NR; Torensma R; de Vries TJ; Schreurs MW; de Bruijn DR; Kater-Baats E; Ruiter DJ; Adema GJ; van Muijen GN; van Kessel AG
Cancer Res; 2000 Mar; 60(6):1654-62. PubMed ID: 10749136
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of variants of melanoma-associated antigen genes and mRNA transcripts in melanomas of dogs.
Stell AJ; Dobson JM; Scase TJ; Catchpole B
Am J Vet Res; 2009 Dec; 70(12):1512-20. PubMed ID: 19951123
[TBL] [Abstract][Full Text] [Related]
30. Systemic interferon-alpha (IFN-alpha) treatment leads to Stat3 inactivation in melanoma precursor lesions.
Kirkwood JM; Farkas DL; Chakraborty A; Dyer KF; Tweardy DJ; Abernethy JL; Edington HD; Donnelly SS; Becker D
Mol Med; 1999 Jan; 5(1):11-20. PubMed ID: 10072444
[TBL] [Abstract][Full Text] [Related]
31. A lineage-specific methylation pattern controls the transcription of the polycistronic mRNA coding MELOE melanoma antigens.
Chalopin B; Florenceau L; Fradin D; Labarrière N; Moreau-Aubry A
Melanoma Res; 2015 Aug; 25(4):279-83. PubMed ID: 25968572
[TBL] [Abstract][Full Text] [Related]
32. Melanoma antigen-encoding gene expression in melanocytic naevi and cutaneous malignant melanomas.
Basarab T; Picard JK; Simpson E; Russell-Jones R
Br J Dermatol; 1999 Jan; 140(1):106-8. PubMed ID: 10215777
[TBL] [Abstract][Full Text] [Related]
33. Decreased expression of human melanoma-associated antigen ME491 along the progression of melanoma pre-canceroses to invasive and metastatic melanomas.
Kondoh M; Ueda M; Ichihashi M; Mishima Y
Melanoma Res; 1993 Aug; 3(4):241-5. PubMed ID: 8219756
[TBL] [Abstract][Full Text] [Related]
34. Dysplastic nevus syndrome. Familial and sporadic precursors of cutaneous melanoma.
Kraemer KH; Greene MH
Dermatol Clin; 1985 Apr; 3(2):225-37. PubMed ID: 3830486
[TBL] [Abstract][Full Text] [Related]
35. Comparative study on driver mutations in primary and metastatic melanomas at a single Japanese institute: A clue for intra- and inter-tumor heterogeneity.
Kaji T; Yamasaki O; Takata M; Otsuka M; Hamada T; Morizane S; Asagoe K; Yanai H; Hirai Y; Umemura H; Iwatsuki K
J Dermatol Sci; 2017 Jan; 85(1):51-57. PubMed ID: 27771229
[TBL] [Abstract][Full Text] [Related]
36. Metastatic potential of human melanoma cells in nude mice--characterisation of phenotype, cytokine secretion and tumour-associated antigens.
Schadendorf D; Fichtner I; Makki A; Alijagic S; Küpper M; Mrowietz U; Henz BM
Br J Cancer; 1996 Jul; 74(2):194-9. PubMed ID: 8688321
[TBL] [Abstract][Full Text] [Related]
37. [Expression of cancer testis (CT) antigens in pediatric and adolescent melanomas].
Behrendt N; Schultewolter T; Busam K; Frosina D; Spagnoli G; Jungbluth A
Pathologe; 2017 Jul; 38(4):303-311. PubMed ID: 28631119
[TBL] [Abstract][Full Text] [Related]
38. [Genetic factors in the development and progression of malignant melanoma].
Rünger TM; Bröcker EB
Hautarzt; 1995 Jun; 46(6):394-9. PubMed ID: 7642382
[TBL] [Abstract][Full Text] [Related]
39. The gene expression signatures of melanoma progression.
Haqq C; Nosrati M; Sudilovsky D; Crothers J; Khodabakhsh D; Pulliam BL; Federman S; Miller JR; Allen RE; Singer MI; Leong SP; Ljung BM; Sagebiel RW; Kashani-Sabet M
Proc Natl Acad Sci U S A; 2005 Apr; 102(17):6092-7. PubMed ID: 15833814
[TBL] [Abstract][Full Text] [Related]
40. Association of early malignant melanoma with nevocytic nevi.
Stolz W; Schmoeckel C; Landthaler M; Braun-Falco O
Cancer; 1989 Feb; 63(3):550-5. PubMed ID: 2643457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
